Breaking News Bar
updated: 9/5/2013 10:09 AM

FDA approves French plant's manufacture of Horizon Pharma drug

Success - Article sent! close

DEERFIELD -- The U.S. Food and Drug Administration has approved Horizon Pharma's use of Sanofi's manufacturing site in Compiègne, France to manufacture the rheumatoid arthritis drug Duexis.

"We have had a successful long-term partnership with Sanofi and are pleased with the FDA's approval of the Compiègne site as an additional manufacturing facility for Duexis," said Hans-Peter Zobel, Ph.D., senior vice president, manufacturing, Horizon Pharma. "This approval provides us a quality backup manufacturing site, enhancing our ability to ensure an adequate long-term supply of Duexis."

Valiant Pharmaceuticals' manufacturing site in Laval, Quebec, previously owned and operated by Sanofi, serves as the primary commercial manufacturing site for Duexis.

Share this page
Comments ()
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.